Constance Delaugerre

12.8k total citations
206 papers, 4.3k citations indexed

About

Constance Delaugerre is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Constance Delaugerre has authored 206 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Infectious Diseases, 131 papers in Virology and 67 papers in Epidemiology. Recurrent topics in Constance Delaugerre's work include HIV Research and Treatment (131 papers), HIV/AIDS drug development and treatment (114 papers) and HIV/AIDS Research and Interventions (91 papers). Constance Delaugerre is often cited by papers focused on HIV Research and Treatment (131 papers), HIV/AIDS drug development and treatment (114 papers) and HIV/AIDS Research and Interventions (91 papers). Constance Delaugerre collaborates with scholars based in France, United States and Ivory Coast. Constance Delaugerre's co-authors include Jean‐Michel Molina, Vincent Cálvez, Christine Katlama, Marie‐Laure Chaix, Christine Rouzioux, Sarah Maylin, Anne‐Geneviève Marcelin, François Simon, Jade Ghosn and Gilles Peytavin and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Constance Delaugerre

199 papers receiving 4.2k citations

Peers

Countries citing papers authored by Constance Delaugerre

Since Specialization

Citations

This map shows the geographic impact of Constance Delaugerre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance Delaugerre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance Delaugerre more than expected).

Fields of papers citing papers by Constance Delaugerre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constance Delaugerre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance Delaugerre. The network helps show where Constance Delaugerre may publish in the future.

Co-authorship network of co-authors of Constance Delaugerre

This figure shows the co-authorship network connecting the top 25 collaborators of Constance Delaugerre. A scholar is included among the top collaborators of Constance Delaugerre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constance Delaugerre. Constance Delaugerre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation	Science Advances	Mathieu F. Chevalier, Vincent Allain et al.	1
2	Enhancing the control of respiratory virus spread: a comprehensive approach integrating airborne virus detection, aerological investigations, and airflow modeling for practical implementation	Infection Control and Hospital Epidemiology	Guillaume Mellon, Nadia Mahjoub et al.	1
3	Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients	Journal of Clinical Virology	Nathalie Schnepf, Nadia Mahjoub et al.	0
4	Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial	Open Forum Infectious Diseases	Lara E. Coelho, Corine Chazallon et al.	2
5	Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023	Journal of Medical Virology	Marie‐Laure Chaix, Karl Stéfic et al.	3
6	BK virus genotypes and humoral response in kidney transplant recipients with BKV associated nephropathy	Transplant Infectious Disease	Julien Gras, M.N. Peraldi et al.	6
7	Optimizing COVID-19 Vaccination Strategy in Pediatric Kidney Transplant Recipients: Humoral and Cellular Response to SARS-CoV-2 mRNA Vaccination	Transplant International	Isabelle Nel, Marina Charbit et al.	3
8	Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients	Vaccine	Alexis Cuffel, Sarah Maylin et al.	6
9	Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis	Open Forum Infectious Diseases	Nathalie De Castro, Kévin Jean et al.	2
10	RACK1 Associates with RNA-Binding Proteins Vigilin and SERBP1 to Facilitate Dengue Virus Replication	Journal of Virology	Marie Pourcelot, Beate M. Kümmerer et al.	25
11	Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study	Journal of Antimicrobial Chemotherapy	Patrick Miailhes, Caroline Lascoux‐Combe et al.	4
12	SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4	The Journal of Experimental Medicine	Fanny Onodi, Lucie Bonnet‐Madin et al.	80
13	Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus–Hepatitis B Virus–Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort	Clinical Infectious Diseases	Patrick Miailhes, Caroline Lascoux‐Combe et al.	4
14	Accessible LAMP-Enabled Rapid Test (ALERT) for Detecting SARS-CoV-2	Viruses	Michael F. Covington, Guy Aidelberg et al.	19
15	HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection	The Journal of Infectious Diseases	Jade Ghosn, Lambert Assoumou et al.	4
16	Incidence of HIV infection with daily or on-demand oral prep with TDF/FTC in france		Jean‐Michel Molina, Jade Ghosn et al.	8
17	Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care	Scientific Reports	Jérôme LeGoff, Solen Kernéis et al.	16
18	Minority HIV‐1 resistant variants in recent infection and in patients who failed first‐line antiretroviral therapy with no detectable resistance‐associated mutations in Thailand	Journal of Medical Virology	Sunee Sirivichayakul, Constance Delaugerre et al.	4
19	Barrière génétique à la résistance des antirétroviraux : Le point sur le raltégravir, premier inhibiteur d’intégrase	Médecine et Maladies Infectieuses	Constance Delaugerre	5
20	Résistance du VIH aux inhibiteurs non nucléosidiques de la transcriptase inverse (INNTI)	Virologie	Constance Delaugerre, Marie‐Laure Chaix	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact